Ajanta Pharma is trading -0.40% lower at Rs 2,673.10 as compared to its last closing price. Ajanta Pharma has been trading in the price range of 2,737.95 & 2,659.00. Ajanta Pharma has given -8.63% in this year & 8.46% in the last 5 days. Ajanta Pharma has TTM P/E ratio 41.00 as compared to the sector P/E of 28.79.There are 10 analysts who have initiated coverage on Ajanta Pharma. There are 4 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 232.88 Crores in its last quarter.Listed peers of Ajanta Pharma include Ipca Laboratories (1.23%), Laurus Labs (-0.18%), Ajanta Pharma (-0.40%).The Mutual Fund holding in Ajanta Pharma was at 15.13% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Ajanta Pharma was at 8.86% in 31 Mar 2025. The FII holding has decreased from the last quarter.
Updated on Apr 23, 2025, 11:01 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Ipca Laboratories | Bullish | 1,462.00 | 1.23 | 37,157.69 | 55.07 | 5.7 | 0.28 | 9.80 |
Laurus Labs | Bullish | 650.45 | -0.18 | 35,075.68 | 213.42 | 8.4 | 0.12 | 20.93 |
Ajanta Pharma | Neutral | 2,673.10 | -0.40 | 33,453.56 | 41.24 | 9.46 | 2.02 | 0.66 |
Suven Pharmaceuticals | Bullish | 1,201.15 | -2.59 | 30,731.01 | 101.08 | 14.92 | - | 1.04 |
Piramal Pharma | Bullish | 223.65 | -0.40 | 29,650.36 | 479.90 | 3.69 | 0.05 | 32.89 |
Meeting Date | Purpose |
---|---|
2025-01-30 | Quarterly Results |
2024-10-28 | Quarterly Results |
2024-07-30 | Quarterly Results |
2024-05-02 | Audited Results & Buy Back of Shares |
2024-01-31 | Quarterly Results & 2nd Interim Dividend |
Ajanta Pharma is trading at 2673.10 as on Wed Apr 23 2025 09:59:46. This is -0.40% lower as compared to its previous closing price of 2683.95.
The market capitalization of Ajanta Pharma is 33453.56 Cr as on Wed Apr 23 2025 09:59:46.
The average broker rating on Ajanta Pharma is Buy. The breakup of analyst rating is given below -
The 52 wk high for Ajanta Pharma is 3485.75 whereas the 52 wk low is 2022.05
Ajanta Pharma can be analyzed on the following key metrics -
Ajanta Pharma reported a net profit of 816.17 Cr in 2024.
The Mutual Fund Shareholding was 15.13% at the end of 31 Mar 2025.